A detailed history of M&G PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, M&G PLC holds 5,665 shares of LLY stock, worth $4.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,665
Previous 11,435 50.46%
Holding current value
$4.5 Million
Previous $10.3 Billion 51.5%
% of portfolio
0.02%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$772.14 - $960.02 $4.46 Million - $5.54 Million
-5,770 Reduced 50.46%
5,665 $5.02 Billion
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $6.77 Million - $9.06 Million
11,435 New
11,435 $8.9 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.